Patent intelligence · US
US 12396924
Adapter for use in a planetary mixer
Adapter for use in a planetary mixer
Patent details — US 12396924
- Jurisdiction
- US
- Status
- granted
- Grant date
- Aug 26, 2025
- Expiration
- Aug 21, 2045
- Applicant
- MEDISCA PHARMACEUTIQUE INC.
- Claims
- 19
- CPC classes
- A61K, A61K31/045, A61K31/135, A61K31/137
Quick answer
US 12396924 (Adapter for use in a planetary mixer) is held by MEDISCA PHARMACEUTIQUE INC.. Status: granted. Granted Aug 26, 2025. Expires Aug 21, 2045 (19 years remaining) — relevant for patent-cliff and LOE planning.
Key facts
- Applicant
- MEDISCA PHARMACEUTIQUE INC.
- Grant date
- Expiration
- Claims
- 19
- CPC classes
- A61K, A61K31/045, A61K31/135, A61K31/137, A61K31/192, A61K31/195
More from MEDISCA PHARMACEUTIQUE INC.
Related pharmaceutical patents in our USPTO index.
-
US 12427173
Use of bacteria, bacterial products, and other immunoregulatory entities in combination with anti-CTLA-4 and/or anti-PD-1 antibodies to treat solid tumor malignancies
granted -
US 12428415
Matriptase 2 inhibitors and uses thereof
granted -
US 12421236
Seven-membered heterocyclic derivative acting as KRAS G12C mutant protein inhibitor
granted -
US 12420085
Synergistic therapies for inter vertebral disc degeneration
granted -
US 12421231
Azaindole derivatives and their use as ERK kinase inhibitors
granted -
US 12403069
Adapter for use in a planetary mixer
granted -
US 12398179
Nanomolar peptides and derivatives to differentially modulate ephrin receptors
granted
Frequently asked questions
What is US patent 12396924?
US 12396924 (Adapter for use in a planetary mixer) is held by MEDISCA PHARMACEUTIQUE INC.. Status: granted. Granted Aug 26, 2025. Expires Aug 21, 2045 (19 years remaining) — relevant for patent-cliff and LOE planning.
Who owns US 12396924?
MEDISCA PHARMACEUTIQUE INC. is listed as the applicant in USPTO PatentsView records indexed by NovaPharmaNews. We track 706 pharmaceutical patents for this assignee.
When does US 12396924 expire?
Our index shows an expiration date of Aug 21, 2045 (19 years from today). Confirm material dates against USPTO, FDA Orange Book, or qualified counsel before contractual decisions.